CVS Group plc (LON:CVSG)
1,302.00
+12.00 (0.93%)
Aug 11, 2026, 4:53 PM GMT
CVS Group Revenue
CVS Group had revenue of 356.90M GBP in the half year ending December 31, 2025, with 11.36% growth. This brings the company's revenue in the last twelve months to 692.80M, up 5.69% year-over-year. In the fiscal year ending June 30, 2025, CVS Group had annual revenue of 673.20M with 5.40% growth.
Revenue (ttm)
692.80M
Revenue Growth
+5.69%
P/S Ratio
1.29
Revenue / Employee
76.98K
Employees
9,000
Market Cap
891.12M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 673.20M | 34.50M | 5.40% |
| Jun 30, 2024 | 638.70M | 49.80M | 8.46% |
| Jun 30, 2023 | 588.90M | 34.70M | 6.26% |
| Jun 30, 2022 | 554.20M | 44.10M | 8.65% |
| Jun 30, 2021 | 510.10M | 82.30M | 19.24% |
| Jun 30, 2020 | 427.80M | 21.30M | 5.24% |
| Jun 30, 2019 | 406.50M | 79.20M | 24.20% |
| Jun 30, 2018 | 327.30M | 55.50M | 20.42% |
| Jun 30, 2017 | 271.80M | 53.70M | 24.62% |
| Jun 30, 2016 | 218.10M | 50.80M | 30.36% |
| Jun 30, 2015 | 167.30M | 24.40M | 17.07% |
| Jun 30, 2014 | 142.90M | 22.80M | 18.98% |
| Jun 30, 2013 | 120.10M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 46.25B |
| GSK plc | 33.20B |
| Haleon | 11.15B |
| Smith & Nephew | 4.77B |
| Spire Healthcare Group | 1.58B |
| Genus | 672.00M |
| HUTCHMED (China) | 413.87M |
| Advanced Medical Solutions Group | 228.94M |
CVS Group News
- 11 days ago - CVS Group upgraded to Overweight from Equal Weight at Barclays - TheFly
- 19 days ago - CVS Group PLC To provide update on Capital Allocation and Returns Transcript - GuruFocus
- 19 days ago - CVS Group Q4 Earnings Call Highlights - MarketBeat
- 19 days ago - CVS Group Earnings Call Transcript: Q4 2026 - Transcripts
- 19 days ago - CVS Group Earnings release: Q4 2026 - Filings
- 20 days ago - CVS Group Slides: Investor presentation - Filings
- 3 months ago - Converium Capital Sends Letter to CVS Group Board Highlighting Company's Undervaluation and Urging £100 Million Share Buyback - Business Wire
- 4 months ago - UK's CVS Group CEO to step down after 7 years at the helm - Reuters